Gesynta is a bio-pharmaceutical company that develops and commercializes novel therapeutics for the treatment of chronic inflammatory diseases. Gesynta was founded in 2017. Gesynta's headquarters is located in Solna, Stockholms län, SE 171 65.
Gesynt... Gesynta's Co-Founder & CEO, Patric Stenberg, currently has an approval
rating of 87%. Gesynta's primary competitors are Attgeno , Inotrem & Cardurion.
There have been no acquisitions found related to Gesynta
Recent investment data cannot be found related to Gesynta